Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-008653
Filing Date
2017-08-14
Accepted
2017-08-14 16:08:55
Documents
58
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0617_chinapharma.htm 10-Q 376843
2 CERTIFICATION f10q0617ex31i_chinapharma.htm EX-31.1 12885
3 CERTIFICATION f10q0617ex31ii_chinapharma.htm EX-31.2 12827
4 CERTIFICATION f10q0617ex32i_chinapharma.htm EX-32.1 7132
  Complete submission text file 0001213900-17-008653.txt   2317867

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cphi-20170630.xml EX-101.INS 323179
6 XBRL SCHEMA FILE cphi-20170630.xsd EX-101.SCH 29744
7 XBRL CALCULATION FILE cphi-20170630_cal.xml EX-101.CAL 49286
8 XBRL DEFINITION FILE cphi-20170630_def.xml EX-101.DEF 40115
9 XBRL LABEL FILE cphi-20170630_lab.xml EX-101.LAB 254122
10 XBRL PRESENTATION FILE cphi-20170630_pre.xml EX-101.PRE 166533
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1230
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 171030195
SIC: 2834 Pharmaceutical Preparations